Sutro Biopharma (STRO) Change in Receivables (2017 - 2025)
Sutro Biopharma (STRO) reported Change in Receivables of $55000.0 for Q4 2025, down 97.2% on a YoY basis from $2.0 million in Q4 2024, and up 101.35% sequentially from -$4.1 million in Q3 2025.
Sutro Biopharma (STRO) Change in Receivables (2017 - 2025) Analysis & Trends
Sutro Biopharma (STRO) has 9 years of Change in Receivables data on file, last reported at $55000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 97.2% year-over-year to $55000.0; the trailing twelve-month figure through Dec 2025 stood at -$4.6 million (up 83.11% YoY), and the FY2025 full-year result was -$4.6 million, up 83.11% from the prior year.
- Change in Receivables rose to $55000.0 in Q4 2025, from -$4.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $86.0 million in Q2 2022 to a low of -$86.4 million in Q3 2022.
- A 5-year average of -$79550.0 and a median of $125000.0 in 2021 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables soared 4348.27% in 2022 and tumbled 19425.4% in 2024, its largest moves.
- Tracing STRO's Change in Receivables over 5 years: stood at $124000.0 in 2021, then tumbled by 3429.03% to -$4.1 million in 2022, then jumped by 571.2% to $19.5 million in 2023, then tumbled by 89.92% to $2.0 million in 2024, then sank by 97.2% to $55000.0 in 2025.
- Business Quant data shows STRO's Change in Receivables at $55000.0 in Q4 2025, -$4.1 million in Q3 2025, and -$5.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | 55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | -4.08 Mn |
| Sep 30, 2025 | -4.08 Mn |
| Jun 30, 2025 | -5.56 Mn |
| Jun 30, 2025 | -5.56 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | -295,000.00 |
| Sep 30, 2024 | -295,000.00 |
| Jun 30, 2024 | -24.35 Mn |
| Jun 30, 2024 | -24.35 Mn |
| Mar 31, 2024 | -4.78 Mn |
| Mar 31, 2024 | -4.78 Mn |
| Dec 31, 2023 | 19.45 Mn |
| Dec 31, 2023 | 19.45 Mn |
| Sep 30, 2023 | 6.63 Mn |
| Sep 30, 2023 | 6.63 Mn |